BioAge Labs (BIOA) Net Shares Issued and Repurchased (2024 - 2026)

BioAge Labs has disclosed Net Shares Issued and Repurchased across 3 years of filings, most recently posting $1.6 million for Q1 2026.

• In Q1 2026, Net Shares Issued and Repurchased fell 42.24% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 42.24% YoY), while the FY2025 annual figure was $3.0 million, down 6.45% from the prior year.
• Net Shares Issued and Repurchased came in at $1.6 million for Q1 2026 at BioAge Labs, down from $3.0 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $3.2 million in Q4 2024 to a low of $1.6 million in Q1 2026.
• Average Net Shares Issued and Repurchased over 3 years is $2.6 million, with a median of $2.9 million recorded in 2025.
• Year-over-year, Net Shares Issued and Repurchased decreased 6.45% in 2025 and plunged 42.24% in 2026.
• Over 3 years, Net Shares Issued and Repurchased stood at $3.2 million in 2024, then dropped by 6.45% to $3.0 million in 2025, then sank by 46.12% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $1.6 million in Q1 2026, $3.0 million in Q4 2025, and $2.8 million in Q1 2025.